Gernot Roessler, Michael Vobig, Peter Walter, Babac AE Mazinani Department of Ophthalmology, RWTH Aachen University, D-52057 Aachen, Germany Purpose: To determine ocular side effects of vardenafil with special regard to color vision and retinal ...
Roessler G +3 more
doaj
The study of the genital system' vessels in patients with erectile disfunction and chronic prostatitis was accomplished using ultrasound Dopplerography and pharmacological testing by phosphodiesterase inhibitors of 5th type (PDEI-5).
P. V. Glybochko +5 more
doaj
Vardenafil in the multidisciplinary management of erectile dysfunction: a narrative review on multidimensional outcomes and clinical integration. [PDF]
Zhou J, Hu S, Ouyang Y, Kong Y, Liu M.
europepmc +1 more source
The PDE5 inhibitor vardenafil enhances glutamatergic transmission through amyloid-beta and cellular prion protein. [PDF]
Kafi MAA +9 more
europepmc +1 more source
Synergy between oral PDE5 inhibitors and topically applied nitric oxide microparticles on the erectile response in a rat model of cavernous nerve injury. [PDF]
Tar MT, Draganski A, Davies KP.
europepmc +1 more source
Effect of vardenafil in long-standing diabetic patients comparing different doses regarding erectile dysfunction, testosterone level and partner satisfaction. [PDF]
Abdellatif AE +6 more
europepmc +1 more source
Proof-of-concept study: APOE4 brain endothelial cells as a phenotypic compound screen. [PDF]
Valencia-Olvera AC +4 more
europepmc +1 more source
The safety and efficacy of phosphodiesterase type 5 inhibitors in the treatment of diabetic erectile dysfunction: a systematic review and meta-analysis. [PDF]
Zhu Z +7 more
europepmc +1 more source
Assessing post-marketing safety of PDE5Is in erectile dysfunction: real-world evidence from the FDA adverse event reporting system. [PDF]
Zhao ZH +4 more
europepmc +1 more source

